Lokman H. Tanriverdi

Dr. Lokman H. Tanriverdi

Medical Pharmacology, Inonu University, Malatya, Turkey (Türkiye)
+1
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
BZBulat A. Ziganshin
Bulat A. Ziganshin
ABAllison E. Bailey
Allison E. Bailey
CCCelinez Coons
Celinez Coons
DDDaniel Dykas
Daniel Dykas
PCParis Charilaou
Paris Charilaou
JEJohn Elefteriades
John Elefteriades

3 October 2017 in Free Radical Research
Verified
Journal Article
Closed access
Lokman H. TanriverdiLokman H. Tanriverdi
Lokman H. Tanriverdi
HPHakan Parlakpinar
Hakan Parlakpinar
Onural OzhanOnural Ozhan
Onural Ozhan
NENecip Ermis
Necip Ermis
APAlaadin Polat
Alaadin Polat
AAAhmet Acet
Ahmet Acet
Preventive and/or therapeutic interventions for ischemic heart disease have gained considerable attention worldwide. We investigated the mechanism(s) underlying cardioprotection of apocynin (APO) and whether it attenuates isoproterenol (ISO)-induced myocardial damage in vivo. Thirty-two male Wistar Albino rats were randomised into four groups (n = 8 for each group): Group I (Control); Group II (ISO), ISO was given intraperitoneally (ip) (150 mg/kg/d) daily for 2 consecutive days; Group III (APO + ISO), APO was applied ip 20 mg/kg 30 min before the first ISO administration and continued for the next 2 d after the second ISO administration; Group IV (ISO + APO), after the ISO treatment on days 1 and 2, 20 mg/kg APO was given ip on days 3 and 4. Cardioprotective effects of APO were evaluated by biochemical values, histopathological observations and the antiapoptotic relative proteins. Mean blood pressure, heart rate, and electrocardiography (ECG) were also monitored. Malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), reduced glutathione (GSH), total oxidant status (TOS), total antioxidant capacity (TAC), oxidative stress index (OSI), caspase-3 and connexin 43 levels were determined. Major ECG changes were observed in the ISO-treated rats. MDA, TOS, OSI and creatine kinase levels decreased and SOD, CAT, GSH and TAC levels increased, indicating that APO reduced cardiac injury and oxidative stress compared with controls. APO also decreased the number of cardiomyocytes with pyknotic nuclei, inflammatory cell infiltration, intracytoplasmic vacuolisation and myofibrils. APO provides preventive and therapeutic effects on ISO-induced myocardial injury in rats by inhibiting reactive oxygen species production, blocking inflammation and enhancing antioxidant status.

18 May 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
FKFerhat Kalkan
Ferhat Kalkan
HPHakan Parlakpinar
Hakan Parlakpinar
ODOlcay M. Disli
Olcay M. Disli
Lokman H. TanriverdiLokman H. Tanriverdi
Lokman H. Tanriverdi
Onural OzhanOnural Ozhan
Onural Ozhan
AAAhmet Acet
Ahmet Acet

1 October 2021 in Tissue and Cell
Verified
Journal Article
Closed access
OKOmer Faruk Koroglu
Omer Faruk Koroglu
MGMehmet Gunata
Mehmet Gunata
NVNigar Vardi
Nigar Vardi
AYAzibe Yıldız
Azibe Yıldız
BABurhan Ates
Burhan Ates
HPHakan Parlakpinar
Hakan Parlakpinar

21 March 2019 in Cardiovascular Toxicology
Verified
Journal Article
Closed access
PDF file
HPHakan Parlakpinar
Hakan Parlakpinar
Onural OzhanOnural Ozhan
Onural Ozhan
NENecip Ermis
Necip Ermis
NVNigar Vardi
Nigar Vardi
YCYilmaz Cigremis
Yilmaz Cigremis
AAAhmet Acet
Ahmet Acet

26 September 2022 in Fundamental & Clinical Pharmacology
Verified
Journal Article
Closed access
Lokman H. TanriverdiLokman H. Tanriverdi
Lokman H. Tanriverdi
Onural OzhanOnural Ozhan
Onural Ozhan
AUAhmet Ulu
Ahmet Ulu
AYAzibe Yıldız
Azibe Yıldız
BABurhan Ateş
Burhan Ateş
HPHakan Parlakpinar
Hakan Parlakpinar